# Diamedica Therapeutics (DMAC): value investors who own it

1 value investor held Diamedica Therapeutics in their Q3 2026 13F, led by Omega Family Office (Leon Cooperman).

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Omega Family Office (Leon Cooperman) | 0.7% | $24.3m | Added +71% | 23 |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/dmac). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.